BSE filing, NSE: AFIL. Summary written from the filing by ALFA Finder's alert engine.
Akme Fintrade (India) Ltd: key numbers
- Share price
- ₹7.31
- Market cap
- ₹317.9 Cr
- Revenue (annual)
- ₹148.8 Cr
- Net profit (annual)
- ₹42.32 Cr
- P/E (TTM)
- 7.2×Sector 19.7×
- Promoter holding
- 38.94%-0.08% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akme Fintrade (India) Ltd
All →Akme Fintrade (India) Debt & Borrowing: ₹50 Cr
Akme Fintrade's board approved ₹50 Crore secured NCD allotment in two series. Series A1 (24 months, 11.40%) and A2 (30 months, 11.60%) will be listed on NSE.
- Value
- ₹50.00 Cr
Akme Fintrade (India) Other Announcement
Akme Fintrade (India) Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Akme Fintrade (India) Debt & Borrowing: ₹25 Cr
Akme Fintrade (India) Limited is raising Rs.25 Crore through the issuance of non-convertible debentures. The debt securities are proposed to be listed on the NSE.
- Value
- ₹25.00 Cr
- Execution
- 24 months
Akme Fintrade (India) Debt & Borrowing: ₹50 Cr
Akme Fintrade (India) Ltd approved the issuance of secured, rated, non-convertible debentures (NCDs) aggregating to ₹50 Crore on a private placement basis.
- Value
- ₹50.00 Cr
Akme Fintrade (India) Capital Structure Change
Akme Fintrade received NSE and BSE trading approval for 1.3 crore preferential allotment shares. The company's listed capital rose to 43,97,49,960 shares post-allotment.
Akme Fintrade (India) Board Meeting Date
Akme Fintrade scheduled its Board of Directors meeting for October 10, 2026. The agenda proposes approval of NCDs up to ₹350 Crore on private placement.
Other board meeting date announcements
All →TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Salzer Electronics Board Meeting Date
Salzer Electronics Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October to 14 November 2026.
Ekansh Concepts Board Meeting Date
Ekansh Concepts has scheduled a board meeting for November 5, 2026, to consider Q2 and H1 FY27 un-audited financial results. No figures are disclosed.
RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.